Andrew Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Andrew Chen has a total of 156 co-authors. Here are the top co-authors by number of shared publications:
- Joseph Caprioli
Glaucoma Division, Stein Eye Institute, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
5 shared publications - Talal A. Chatila
Division of Immunology, Boston Children’s Hospital, Boston, MA, USA
5 shared publications Fei Yu
Jules Stein Eye Institute, Glaucoma Division, David Geffen School of Medicine at UCLA (University of California, Los Angeles)
4 shared publicationsAbdelmonem Afifi
Department of Biostatistics, Jonathan and Karin Fielding School of Public Health at UCLA
3 shared publicationsAaron Y. Lee
Department of Ophthalmology, University of Washington, Seattle, Washington, United States
2 shared publications- Clinton B. Mathias
Department of Nutritional Sciences, University of Connecticut , Storrs, CT
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Wolters Kluwer Health in Journal of Glaucoma
Intraocular Pressure Fluctuation Before and After Phacoemulsification in Eyes With Open-Angle Glaucoma
Précis: Although phacoemulsification lowered mean intraocular pressure (IOP) for this entire cohort of open-angle glaucoma eyes, sub-group analysis showed eyes without any medication changes during follow-up period had no change in mean IOP nor fluctuation. Purpose: To examine long-term intraocular pressure (IOP) fluctuation in open-angle glaucoma (OAG) patients pre- and post-phacoemulsification. Patients and Methods: Review of OAG patients who had uncomplicated phacoemulsification. Demographic data, IOP, IOP fluctuation [SD and coefficient of variation (CoV)] and glaucoma medication changes pre and post-phacoemulsification were collected. Analysis included investigation of 4 subgroups based on medication change status. Results: Among 115 eyes meeting inclusion criteria (mean ± SD age 72.5± 9.0 y, pre-operative IOP 15.4±2.8 mmHg, number of medications 2.1±1.1, and visual field mean deviation –5.0±5.1 dB), IOP mean, SD, range, maximum, and minimum were lower after surgery (p≤0.002), while CoV was not different ( P =0.095). Eyes with medication changes pre- but not post-operative (N=27) had improved IOP mean, SD and CoV ( P ≤0.037) while eyes with medication changes post- but not pre-operative (N=33) and changes both pre- and post-operative (N=25) had improved IOP mean but not SD or CoV ( P ≥0.201). Eyes without medication changes had no change in IOP fluctuation ( P ≥0.101). Risk factors associated with an increase in postoperative IOP SD of at least 0.5 mmHg included lower preoperative IOP mean and SD, higher pre-operative IOP maximum, thinner corneal central thickness, postoperative medication changes, and pseudoexfoliation glaucoma ( P ≤0.046). Conclusion: Phacoemulsification decreased mean IOP and SD in the entire cohort, but medication changes before and after surgery significantly influenced IOP SD and CoV. This should be considered in future studies of long-term IOP fluctuation in glaucoma patients.
- 7 October 2026
- Published by Wolters Kluwer Health in Journal of Glaucoma
Open AccessIntraocular Pressure Fluctuation Before and After Phacoemulsification in Eyes With Open-Angle Glaucoma
Précis: Although phacoemulsification lowered mean intraocular pressure (IOP) for this entire cohort of open-angle glaucoma eyes, sub-group analysis showed eyes without any medication changes during follow-up period had no change in mean IOP nor fluctuation. Purpose: To examine long-term intraocular pressure (IOP) fluctuation in open-angle glaucoma (OAG) patients pre- and post-phacoemulsification. Patients and Methods: Review of OAG patients who had uncomplicated phacoemulsification. Demographic data, IOP, IOP fluctuation [SD and coefficient of variation (CoV)] and glaucoma medication changes pre and post-phacoemulsification were collected. Analysis included investigation of 4 subgroups based on medication change status. Results: Among 115 eyes meeting inclusion criteria (mean ± SD age 72.5± 9.0 y, pre-operative IOP 15.4±2.8 mmHg, number of medications 2.1±1.1, and visual field mean deviation –5.0±5.1 dB), IOP mean, SD, range, maximum, and minimum were lower after surgery (p≤0.002), while CoV was not different ( P =0.095). Eyes with medication changes pre- but not post-operative (N=27) had improved IOP mean, SD and CoV ( P ≤0.037) while eyes with medication changes post- but not pre-operative (N=33) and changes both pre- and post-operative (N=25) had improved IOP mean but not SD or CoV ( P ≥0.201). Eyes without medication changes had no change in IOP fluctuation ( P ≥0.101). Risk factors associated with an increase in postoperative IOP SD of at least 0.5 mmHg included lower preoperative IOP mean and SD, higher pre-operative IOP maximum, thinner corneal central thickness, postoperative medication changes, and pseudoexfoliation glaucoma ( P ≤0.046). Conclusion: Phacoemulsification decreased mean IOP and SD in the entire cohort, but medication changes before and after surgery significantly influenced IOP SD and CoV. This should be considered in future studies of long-term IOP fluctuation in glaucoma patients.
- 23 June 2026
- Published by Wolters Kluwer Health in International Ophthalmology Clinics
- Vol. 66 (3) , 23-25
Rationale for Preservative-free Glaucoma Drops
Benzalkonium chloride (BAK) is the most widely used preservative in multidose glaucoma eye drops. Medical management of glaucoma often requires the chronic use of preserved eye drops, resulting in a high incidence of BAK‑associated ocular discomfort, ocular surface disease, accumulation within ocular structures, and inflammatory tissue changes. The use of BAK has also been associated with reduced surgical success in trabeculectomy. Although alternative preservatives exist, they have also been associated with some toxic effects. Switching from BAK‑containing formulations to preservative‑free (PF) formulations results in significantly fewer side effects, improved ocular surface disease, and enhanced patient comfort. However, barriers such as cost and ease of use have impeded the more widespread adoption of PF glaucoma drops.
- 23 June 2026
- Published by Wolters Kluwer Health in International Ophthalmology Clinics
- Vol. 66 (3) , 23-25
Rationale for Preservative-free Glaucoma Drops
Benzalkonium chloride (BAK) is the most widely used preservative in multidose glaucoma eye drops. Medical management of glaucoma often requires the chronic use of preserved eye drops, resulting in a high incidence of BAK‑associated ocular discomfort, ocular surface disease, accumulation within ocular structures, and inflammatory tissue changes. The use of BAK has also been associated with reduced surgical success in trabeculectomy. Although alternative preservatives exist, they have also been associated with some toxic effects. Switching from BAK‑containing formulations to preservative‑free (PF) formulations results in significantly fewer side effects, improved ocular surface disease, and enhanced patient comfort. However, barriers such as cost and ease of use have impeded the more widespread adoption of PF glaucoma drops.
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 2793-2802
The Prevalence of Ophthalmic Diagnoses and Exam Findings in Emergency Department Consults at Two Academic Hospitals
Purpose: To report the prevalence of abnormal ophthalmic exam findings in Emergency Department (ED) ophthalmology consultations and provide foundational data for assessing ancillary diagnostic tools’ effectiveness in an acute care setting. Patients and Methods: We reviewed ophthalmic exam findings from consultations at Harborview Medical Center and University of Washington Medical Center EDs (Seattle, WA) between January 1, 2022, and December 31, 2022. Data included visual acuity (VA), intraocular pressure (IOP), visual field by confrontation (CVF), extraocular motility (EOM), pupil exam, slit lamp, and dilated exam findings. Descriptive statistics were calculated for continuous and categorical variables. Results: A total of 2087 consults for 1946 patients were included. VA was 20/40 or better in 61.9% of right eyes and 62.4% of left eyes. Afferent pupillary defect (APD) was present in 12.6% eyes. The average IOP was 16.1 mmHg for the right eye and 16.1 mmHg for the left eye. Abnormal EOM in either eye or both eyes were reported in 17.5% and 2.5%, respectively, while abnormal CVF were reported in 16.9%; with homonymous defects in 0.8%. The most common slit lamp exam findings included cataract (31.94%), conjunctival injection (31.2%), and superficial punctate epithelial erosions (29.6%). The most common funduscopic findings were retinal hemorrhage (14.0% peripheral and 6.3% macular), posterior vitreous detachment (9.7%), and retinal vascular attenuation (6.7%). Conclusion: This comprehensive report of findings of ED ophthalmic consultations can be used as a foundational pretest measure for guiding the implementation of appropriate ancillary diagnostic tools for emergency ophthalmic care.
- 1 August 2025
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 19, 2793-2802
Open AccessThe Prevalence of Ophthalmic Diagnoses and Exam Findings in Emergency Department Consults at Two Academic Hospitals
Purpose: To report the prevalence of abnormal ophthalmic exam findings in Emergency Department (ED) ophthalmology consultations and provide foundational data for assessing ancillary diagnostic tools’ effectiveness in an acute care setting. Patients and Methods: We reviewed ophthalmic exam findings from consultations at Harborview Medical Center and University of Washington Medical Center EDs (Seattle, WA) between January 1, 2022, and December 31, 2022. Data included visual acuity (VA), intraocular pressure (IOP), visual field by confrontation (CVF), extraocular motility (EOM), pupil exam, slit lamp, and dilated exam findings. Descriptive statistics were calculated for continuous and categorical variables. Results: A total of 2087 consults for 1946 patients were included. VA was 20/40 or better in 61.9% of right eyes and 62.4% of left eyes. Afferent pupillary defect (APD) was present in 12.6% eyes. The average IOP was 16.1 mmHg for the right eye and 16.1 mmHg for the left eye. Abnormal EOM in either eye or both eyes were reported in 17.5% and 2.5%, respectively, while abnormal CVF were reported in 16.9%; with homonymous defects in 0.8%. The most common slit lamp exam findings included cataract (31.94%), conjunctival injection (31.2%), and superficial punctate epithelial erosions (29.6%). The most common funduscopic findings were retinal hemorrhage (14.0% peripheral and 6.3% macular), posterior vitreous detachment (9.7%), and retinal vascular attenuation (6.7%). Conclusion: This comprehensive report of findings of ED ophthalmic consultations can be used as a foundational pretest measure for guiding the implementation of appropriate ancillary diagnostic tools for emergency ophthalmic care.
- 13 March 2025
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 34 (5) , 394-399
Social Vulnerability Associated With Frequency of Visual Field and Optical Coherence Tomography Testing in Glaucoma Patients
Precis: Higher Social Vulnerability Index scores, limited-English proficiency, and retirement/disability status were associated with lower odds of completing one visual field and optical coherence tomography/year in glaucoma patients. Purpose: To assess the correlation between sociodemographic factors and the Social Vulnerability Index to the likelihood of not receiving 1 visual field test and 1 retinal nerve fiber layer optical coherence tomography test per year. Methods: Patient records with glaucoma living in Washington state from a single academic institution (2014–2021) were reviewed. Those with a single visit, an address with no Social Vulnerability Index score, or a diagnosis relating to pre-glaucoma, glaucoma-suspect, or ocular hypertension were excluded. Demographic data, Social Vulnerability Index scores, and the number of visual fields and optical coherence tomography were collected. Patients were classified as meeting testing criteria if they had at least one visual field and optical coherence tomography per year. Logistic regression was used to assess whether sociodemographic factors and Social Vulnerability Index scores were associated with not meeting testing criteria. Results: Three thousand nine hundred seventy-one patients were included: 1470 (37.0%), 1834 (46.2%), and 1413 (35.6%), had at least 1 visual field/year, at least 1 optical coherence tomography/year, and at least 1 visual field and 1 optical coherence tomography/year, respectively. On average 0.8±0.6 visual field/year and 0.9±0.6 optical coherence tomography/year were performed. Limited English proficiency (P=0.009), being disabled/retired (P=0.003), and higher Social Vulnerability Index scores (P<0.001) were associated with higher odds of not meeting testing criteria. Conclusions: Although higher Social Vulnerability Index scores were linked to reduced odds of glaucoma testing, specific sociodemographic factors—such as limited English proficiency and retirement/disability—further reduced the odds.
- 13 March 2025
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 34 (5) , 394-399
Social Vulnerability Associated With Frequency of Visual Field and Optical Coherence Tomography Testing in Glaucoma Patients
Precis: Higher Social Vulnerability Index scores, limited-English proficiency, and retirement/disability status were associated with lower odds of completing one visual field and optical coherence tomography/year in glaucoma patients. Purpose: To assess the correlation between sociodemographic factors and the Social Vulnerability Index to the likelihood of not receiving 1 visual field test and 1 retinal nerve fiber layer optical coherence tomography test per year. Methods: Patient records with glaucoma living in Washington state from a single academic institution (2014–2021) were reviewed. Those with a single visit, an address with no Social Vulnerability Index score, or a diagnosis relating to pre-glaucoma, glaucoma-suspect, or ocular hypertension were excluded. Demographic data, Social Vulnerability Index scores, and the number of visual fields and optical coherence tomography were collected. Patients were classified as meeting testing criteria if they had at least one visual field and optical coherence tomography per year. Logistic regression was used to assess whether sociodemographic factors and Social Vulnerability Index scores were associated with not meeting testing criteria. Results: Three thousand nine hundred seventy-one patients were included: 1470 (37.0%), 1834 (46.2%), and 1413 (35.6%), had at least 1 visual field/year, at least 1 optical coherence tomography/year, and at least 1 visual field and 1 optical coherence tomography/year, respectively. On average 0.8±0.6 visual field/year and 0.9±0.6 optical coherence tomography/year were performed. Limited English proficiency (P=0.009), being disabled/retired (P=0.003), and higher Social Vulnerability Index scores (P<0.001) were associated with higher odds of not meeting testing criteria. Conclusions: Although higher Social Vulnerability Index scores were linked to reduced odds of glaucoma testing, specific sociodemographic factors—such as limited English proficiency and retirement/disability—further reduced the odds.
- Open Access
- 14 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0317354
In vivo imaging of mitochondrial function in normal, glaucoma suspect, and glaucoma eyes
To investigate macula and optic nerve head (ONH) mitochondrial metabolic activity using flavoprotein fluorescence (FPF) in normal, glaucoma suspect (GS), and open-angle glaucoma (OAG) eyes we performed a cross-sectional, observational study of FPF in normal, GS, and OAG eyes. The macula and ONH of each eye was scanned and analyzed with a commercially available FPF measuring device (OcuMet Beacon, OcuSciences Inc., Ann Arbor, MI). One-way analysis of variance was used to compare macula and ONH FPF scores between groups. Linear regression models investigated the correlation between FPF scores and structural and functional parameters. We included 25 normal, 16 GS, and 54 OAG eyes. The average age in years ± SD for normal, GS, and OAG groups was 60.6 ±17.4, 67.8 ± 10.3, and 67.9 ± 11.6, respectively (P = 0.064). There was no significant difference in gender, race/ethnicity, visual acuity, and intraocular pressure between groups. OAG eyes had larger cup-to-disc ratio, thinner retinal nerve fiber and macula thicknesses, and worse visual field indices compared to normal and GS eyes (P ≤ 0.018). There was no significant difference in any FPF metric between the study groups in either the macula or the ONH, despite normalizing FPF data for structural differences between groups (e.g. retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness). In conclusion, no significant differences in metabolic activity as measured by FPF were found in macula and ONH FPF scores using the integrated clinician report generator between normal, GS, and OAG eyes. Further research is needed to evaluate the role of mitochondrial metabolic activity measurements in glaucoma.
- 14 January 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (1) , e0317354
Open AccessIn vivo imaging of mitochondrial function in normal, glaucoma suspect, and glaucoma eyes
To investigate macula and optic nerve head (ONH) mitochondrial metabolic activity using flavoprotein fluorescence (FPF) in normal, glaucoma suspect (GS), and open-angle glaucoma (OAG) eyes we performed a cross-sectional, observational study of FPF in normal, GS, and OAG eyes. The macula and ONH of each eye was scanned and analyzed with a commercially available FPF measuring device (OcuMet Beacon, OcuSciences Inc., Ann Arbor, MI). One-way analysis of variance was used to compare macula and ONH FPF scores between groups. Linear regression models investigated the correlation between FPF scores and structural and functional parameters. We included 25 normal, 16 GS, and 54 OAG eyes. The average age in years ± SD for normal, GS, and OAG groups was 60.6 ±17.4, 67.8 ± 10.3, and 67.9 ± 11.6, respectively (P = 0.064). There was no significant difference in gender, race/ethnicity, visual acuity, and intraocular pressure between groups. OAG eyes had larger cup-to-disc ratio, thinner retinal nerve fiber and macula thicknesses, and worse visual field indices compared to normal and GS eyes (P ≤ 0.018). There was no significant difference in any FPF metric between the study groups in either the macula or the ONH, despite normalizing FPF data for structural differences between groups (e.g. retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness). In conclusion, no significant differences in metabolic activity as measured by FPF were found in macula and ONH FPF scores using the integrated clinician report generator between normal, GS, and OAG eyes. Further research is needed to evaluate the role of mitochondrial metabolic activity measurements in glaucoma.
- Open Access
- 25 October 2024
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 34 (1) , 1-6
The Association Between Intermittent Fasting and Glaucoma
Précis: Intermittent fasting was not associated with a decreased risk of glaucoma diagnosis overall. Objective: To examine the association between intermittent fasting (“breakfast skipping”) and glaucoma in the National Health and Nutrition Examination Survey (NHANES). Patients and Methods: Retrospective, cross-sectional study of adult participants of the 2005–2008 NHANES aged 40 years and older. Intermittent fasting was defined as skipping breakfast on both days of the NHANES dietary interview. Glaucoma was defined by (1) self-reported glaucoma diagnosis, (2) cup-to-disc (CDR) ≥0.6 in at least one eye, and (3) possible, probable, or definite glaucoma based on clinical judgment of retinal imaging of individuals with CDR ≥0.6 in at least one eye. Covariates included age, sex, race/ethnicity, body mass index, blood pressure, and waist circumference. χ2 and Fisher exact test were used for categorical variables and the t test for continuous variables. All data were weighted based on the NHANES multistage sampling design. Results: The population included 7081 individuals 40 years or older, of whom 946 (13.4%) reported skipping breakfast on both interview days; 482 (6.8%) individuals self-reported glaucoma diagnosis, 549 (7.8%) individuals had glaucoma based on CDR ≥0.6, and 343 (6.0%) individuals had glaucoma based on clinical judgment. Diagnosis of glaucoma by all definitions was associated with older age and black or Latinx/Hispanic ethnicity (P = 0.004) but was not associated with intermittent fasting status (P = 0.151). Conclusions: In the 2005–2008 NHANES population, intermittent fasting, defined as breakfast skipping, was not associated with decreased risk of glaucoma diagnosis overall. Further studies are needed to examine the potential effects of intermittent fasting on glaucoma risk.
- 25 October 2024
- Published by Wolters Kluwer Health in Journal of Glaucoma
- Vol. 34 (1) , 1-6
Open AccessThe Association Between Intermittent Fasting and Glaucoma
Précis: Intermittent fasting was not associated with a decreased risk of glaucoma diagnosis overall. Objective: To examine the association between intermittent fasting (“breakfast skipping”) and glaucoma in the National Health and Nutrition Examination Survey (NHANES). Patients and Methods: Retrospective, cross-sectional study of adult participants of the 2005–2008 NHANES aged 40 years and older. Intermittent fasting was defined as skipping breakfast on both days of the NHANES dietary interview. Glaucoma was defined by (1) self-reported glaucoma diagnosis, (2) cup-to-disc (CDR) ≥0.6 in at least one eye, and (3) possible, probable, or definite glaucoma based on clinical judgment of retinal imaging of individuals with CDR ≥0.6 in at least one eye. Covariates included age, sex, race/ethnicity, body mass index, blood pressure, and waist circumference. χ2 and Fisher exact test were used for categorical variables and the t test for continuous variables. All data were weighted based on the NHANES multistage sampling design. Results: The population included 7081 individuals 40 years or older, of whom 946 (13.4%) reported skipping breakfast on both interview days; 482 (6.8%) individuals self-reported glaucoma diagnosis, 549 (7.8%) individuals had glaucoma based on CDR ≥0.6, and 343 (6.0%) individuals had glaucoma based on clinical judgment. Diagnosis of glaucoma by all definitions was associated with older age and black or Latinx/Hispanic ethnicity (P = 0.004) but was not associated with intermittent fasting status (P = 0.151). Conclusions: In the 2005–2008 NHANES population, intermittent fasting, defined as breakfast skipping, was not associated with decreased risk of glaucoma diagnosis overall. Further studies are needed to examine the potential effects of intermittent fasting on glaucoma risk.
- Open Access
- 4 May 2023
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2023, 1-4
Postoperative Endophthalmitis after Combined Cataract Extraction and iStent Inject Implantation
Purpose. To report a case of postoperative endophthalmitis after combined cataract extraction and iStent inject implantation. Observation. A 70-year-old male with a nuclear sclerotic cataract and primary open-angle glaucoma underwent an uneventful phacoemulsification cataract extraction with implantation of an intraocular lens and an iStent inject trabecular bypass stent. The patient was prescribed a postoperative regimen of ofloxacin 0.3 and prednisolone acetate 1, 1 drop four times a day each. On postoperative day five, he presented to the emergency room for eye pain and had 4+ mixed cells in the anterior chamber (AC) without hypopyon or vitritis on exam. Prednisolone 1 eye drops were increased from four times a day to every two hours while awake. Overnight, he developed worsening vision and severe eye pain. The next morning, he was found to have increased AC cells, vitritis, and intraretinal hemorrhages and was diagnosed with endophthalmitis. The patient underwent a vitreous tap and intravitreal injections of vancomycin (1mg/0.1mL) and amikacin (0.4mg/0.1mL). Cultures grew Staphylococcus epidermidis. Lab work-up revealed underlying neutropenia. Visual acuity eventually recovered to 20/20. Conclusion and Importance. This report highlights a case of endophthalmitis associated with placement of the iStent inject. The infection was well-controlled after administration of intravitreal antibiotics without removal of the iStent inject, and visual acuity eventually recovered to 20/20. Surgeons should be aware of endophthalmitis risk following combined iStent inject placement, and good recovery is possible without removal of the implant.
- 4 May 2023
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2023, 1-4
Open AccessPostoperative Endophthalmitis after Combined Cataract Extraction and iStent Inject Implantation
Purpose. To report a case of postoperative endophthalmitis after combined cataract extraction and iStent inject implantation. Observation. A 70-year-old male with a nuclear sclerotic cataract and primary open-angle glaucoma underwent an uneventful phacoemulsification cataract extraction with implantation of an intraocular lens and an iStent inject trabecular bypass stent. The patient was prescribed a postoperative regimen of ofloxacin 0.3 and prednisolone acetate 1, 1 drop four times a day each. On postoperative day five, he presented to the emergency room for eye pain and had 4+ mixed cells in the anterior chamber (AC) without hypopyon or vitritis on exam. Prednisolone 1 eye drops were increased from four times a day to every two hours while awake. Overnight, he developed worsening vision and severe eye pain. The next morning, he was found to have increased AC cells, vitritis, and intraretinal hemorrhages and was diagnosed with endophthalmitis. The patient underwent a vitreous tap and intravitreal injections of vancomycin (1mg/0.1mL) and amikacin (0.4mg/0.1mL). Cultures grew Staphylococcus epidermidis. Lab work-up revealed underlying neutropenia. Visual acuity eventually recovered to 20/20. Conclusion and Importance. This report highlights a case of endophthalmitis associated with placement of the iStent inject. The infection was well-controlled after administration of intravitreal antibiotics without removal of the iStent inject, and visual acuity eventually recovered to 20/20. Surgeons should be aware of endophthalmitis risk following combined iStent inject placement, and good recovery is possible without removal of the implant.
- Open Access
- 27 July 2022
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 243, 118-124
Visual Field Endpoints for Neuroprotective Trials: A Case for AI-Driven Patient Enrichment
- 27 July 2022
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 243, 118-124
Open AccessVisual Field Endpoints for Neuroprotective Trials: A Case for AI-Driven Patient Enrichment
- 21 February 2022
- Published by Elsevier in Ophthalmology
- Vol. 129 (7) , 781-791
Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging
- 21 February 2022
- Published by Elsevier in Ophthalmology
- Vol. 129 (7) , 781-791
Policy-Driven, Multimodal Deep Learning for Predicting Visual Fields from the Optic Disc and OCT Imaging
- 14 October 2021
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 23 (5)
Valproate Efficacy for Agitation Management in a Patient With Paroxysmal Sympathetic Hyperactivity Due to Traumatic Brain Injury
Paroxysmal sympathetic hyperactivity (PSH) is characterized by symptoms of sympathetic stimulation and agitation, hypertonia, and spasticity. In this case, valproate was used to treat aggression in a patient with PSH following traumatic brain injury.
- 14 October 2021
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 23 (5)
Valproate Efficacy for Agitation Management in a Patient With Paroxysmal Sympathetic Hyperactivity Due to Traumatic Brain Injury
Paroxysmal sympathetic hyperactivity (PSH) is characterized by symptoms of sympathetic stimulation and agitation, hypertonia, and spasticity. In this case, valproate was used to treat aggression in a patient with PSH following traumatic brain injury.